Well its one instance where both sides will want to partner. There is a patent cliff in these cardio-health drugs, while on the AMRN side they would like someone to conduct the Outcomes study. Basically it will be of question of price. But any deal is probably several months away, as negotiations take time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.